thurs morning, page-100

If Ropren was FDA approved SLA would be in double dollar figures. Fact is that it isnt - glad you noticed.

SLA is a relatively new player in terms of having a commerical product on the market.

Nobody has suggested that Ropren would be US$18,000 a course. I merely suggested that it could be UP TO US$18,000 a course based on the premise that a competing treatment was going at that price.

So please dont miscontrue my posts. I dont think my respect for you could get any lower.